Therapeutic Strategies Targeting Anti-CD47 Therapies in Glioblastoma Multiforme: Lead or Dead End? [PDF]
Buliman A +4 more
europepmc +1 more source
Clinical outcomes and safety of CD47-targeted immunotherapies across hematologic malignancies: a systematic review of monoclonal antibodies and fusion proteins in combination strategies. [PDF]
Mirza W +4 more
europepmc +1 more source
Cancer Immunotherapy via Disruption of Integrin αvβ3 and CD47 Costabilization on Cancer Cell Surface. [PDF]
Yu PC +12 more
europepmc +1 more source
GATAD2B promotes ovarian cancer malignant progression via MYC/CD47 Axis. [PDF]
Guo T +6 more
europepmc +1 more source
Prognostic importance of CD47 expression on survival of colorectal cancer. [PDF]
Aktepe OH +10 more
europepmc +1 more source
CD47-Targeted Therapy in Cancer Immunotherapy: At a Crossroads of Promise and Challenge. [PDF]
Guo X, Fu Y, Baran N, Ma W.
europepmc +1 more source
On-demand cancer immunotherapy via single-cell encapsulation of synthetic circuit-engineered cells. [PDF]
Zhao Y +6 more
europepmc +1 more source

